Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
198% dehydrated alcohol1件: Ethanol4件: D00068 ,
D02798 ,
D04855 ,
D06542 		--1件: 298
2A04AD10----1件: 298
3Acarbose1件: Acarbose1件: D00216 5件: AMY2A,
AMY2B,
GAA,
GANC,
MGAM 💬		7件: Carbohydrate digestion and absorption, Galactose metabolism, Lysosome, Metabolic pathways, Pancreatic secretion, Salivary secretion, Starch and sucrose metabolism 💬1件: 298
4Acetate1件: Acetate---43件: 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299
5Acetyl-L-carnitine2件: Acetylcarnitine,
Levocarnitine		3件: D02030 ,
D02176 ,
D04713 		--1件: 298
6Acetyl-L-carnitine 1000mg 2X per day for 3 months2件: Acetylcarnitine,
Levocarnitine		3件: D02030 ,
D02176 ,
D04713 		--1件: 298
7Acetylcysteine1件: Acetylcysteine1件: D00221 --20件: 6, 13, 19, 20, 34, 49, 51, 53, 58, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337
8Alanine1件: Alanine1件: D00012 --5件: 6, 13, 251, 298, 299
9Alcohol1件: Ethanol4件: D00068 ,
D02798 ,
D04855 ,
D06542 		--4件: 13, 58, 279, 298
10Alpha 1-Antitrypsin1件: Alpha-1-proteinase inhibitor---2件: 231, 298
11Amino acids1件: Amino acids---3件: 70, 240, 298
12Amlodipine1件: Amlodipine3件: D00615 ,
D02914 ,
D07450 		4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 51, 67, 298
13Amlodipine (drug)1件: Amlodipine3件: D00615 ,
D02914 ,
D07450 		4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 298
14Analgesics----1件: 298
15Antioxidant plus Pregabalin1件: Pregabalin1件: D02716 4件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4 💬		7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬1件: 298
16Antioxidants----3件: 90, 298, 310
17ANTOX----1件: 298
18ANTOX (vers) 1.2----1件: 298
19ANTOX (vers.)1.2----1件: 298
20Antox version 1.2----1件: 298
21Ascorbic acid1件: Ascorbic acid1件: D00018 --4件: 10, 97, 206, 298
22Autologous mesenchymal stromal cell----2件: 96, 298
23Behavioral: smoking and alcohol assumption1件: Ethanol4件: D00068 ,
D02798 ,
D04855 ,
D06542 		--1件: 298
24Benzoyl-L-tyrosyl-[1-13C]alanine (Bz-Tyr-Ala)2件: Alanine,
Tyrosine		2件: D00012 ,
D00022 		--1件: 298
25Bone marrow-derived mesenchymal stem cells----1件: 298
26Bupivacaine1件: Bupivacaine2件: D01450 ,
D07552 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬8件: 46, 51, 53, 70, 96, 168, 226, 298
27Bupivicaine alone----1件: 298
28Buprenorphine1件: Buprenorphine2件: D00836 ,
D07132 		2件: OPRK1,
OPRM1 💬		3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬3件: 46, 70, 298
29Calcium1件: Calcium---30件: 3, 6, 13, 15, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 256, 265, 274, 298, 299
30Calcium, Dietary1件: Calcium---1件: 298
31Carbon1件: Activated charcoal---9件: 6, 46, 50, 51, 85, 86, 96, 97, 298
32Carbon monoxide2件: Activated charcoal,
Carbon monoxide		1件: D09706 --3件: 85, 86, 298
33Carnitine1件: Levocarnitine3件: D02030 ,
D02176 ,
D04713 		--9件: 5, 13, 58, 86, 96, 97, 265, 298, 316
34Celiac Block with triamcinolone and bupivicaine1件: Triamcinolone5件: D00385 ,
D00983 ,
D00984 ,
D00985 ,
D06216 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 298
35CHOLECALCIFEROL1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬10件: 13, 19, 34, 46, 49, 75, 96, 97, 298, 299
36CREON----2件: 298, 299
37Creon 10000----2件: 298, 299
38Creon 25000----2件: 298, 299
39Creon36™----1件: 298
40Diagnostic Test: genetic sequencing----1件: 298
41Diagnostic Test: Hemoglobin A1c1件: Hemoglobin---1件: 298
42Diagnostic Test: Mixed Meal Tolerance Test----1件: 298
43Diagnostic Test: Other exploratory blood biomarkers----1件: 298
44Diazepam1件: Diazepam1件: D00293 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬3件: 46, 155, 298
45Dronabinol1件: Dronabinol1件: D00306 2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬5件: 2, 13, 46, 271, 298
46Endoscopic drainage of the main pancreatic duct----1件: 298
47Ensure Surgical----1件: 298
48ERCP with Bupivacaine infusion1件: Bupivacaine2件: D01450 ,
D07552 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 298
49Esomeprazole1件: Esomeprazole4件: D01984 ,
D04056 ,
D07917 ,
D09339 		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬8件: 13, 46, 86, 98, 107, 113, 298, 299
50Etanercept1件: Etanercept1件: D00742 2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬16件: 15, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285, 298
51EUR-1008 (APT-1008) High Dose----1件: 298
52EUR-1008 (APT-1008) Low Dose----1件: 298
53EUR-1066-A----1件: 298
54EUR-1066-B----1件: 298
55EUS procedure with drug injection----1件: 298
56Extracorporeal shock wave lithotripsy----1件: 298
57Extracorporeal shock wave lithotripsy and endoscopic drainage of the main pancreatic duct----1件: 298
58Fluimucil----4件: 85, 94, 193, 298
59FLUIMUCIL*20CPR EFF 600MG----2件: 94, 298
60GABAPENTIN1件: Gabapentin1件: D00332 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬		9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬5件: 6, 13, 19, 70, 298
61Gabapentin prescriptions1件: Gabapentin1件: D00332 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬		9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 298
62Gold1件: Gold---43件: 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 171, 193, 218, 222, 224, 227, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318
63Helopanflat Mono®----1件: 298
64Hemoglobin1件: Hemoglobin---1件: 298
65Human Secretin1件: Secretin human---1件: 298
66Hydroxychloroquine1件: Hydroxychloroquine1件: D08050 --27件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299
67Indomethacin1件: Indomethacin3件: D00141 ,
D01565 ,
D02110 		2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬3件: 225, 271, 298
68Intra Plexus Triamcinolone and Bupivicaine Injection1件: Triamcinolone5件: D00385 ,
D00983 ,
D00984 ,
D00985 ,
D06216 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 298
69Kreon 25000----2件: 298, 299
70L-Carnitine1件: Levocarnitine3件: D02030 ,
D02176 ,
D04713 		--7件: 13, 86, 96, 97, 265, 298, 316
71Lannacher----1件: 298
72Lanreotide1件: Lanreotide---4件: 67, 73, 85, 298
73LANREOTIDE ACETATE2件: Acetate,
Lanreotide		---4件: 67, 73, 85, 298
74LIPASE----2件: 298, 299
75Liprotamase----2件: 298, 299
76Lyrica1件: Pregabalin1件: D02716 4件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4 💬		7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬1件: 298
77Lyrica®----1件: 298
78Magnesiocard 2.5mmol----1件: 298
79Magnesium1件: Magnesium---19件: 3, 6, 11, 13, 15, 46, 64, 70, 93, 97, 166, 225, 235, 256, 284, 291, 296, 297, 298
80Magnesium aspartate2件: Magnesium,
Magnesium aspartate		1件: D02026 --1件: 298
81MAGNESIUM ASPARTATE HYDROCHLORIDE3件: Magnesium,
Magnesium aspartate,
Magnesium aspartate hydrochloride		1件: D02026 --1件: 298
82Mayo Interactive Breath Hold Monitor1件: Methamidophos---2件: 298, 300
83Metamizole1件: Metamizole1件: D08188 --1件: 298
84Methionine1件: Methionine2件: D00019 ,
D04983 		--7件: 34, 75, 84, 93, 229, 298, 300
85Mezym F----1件: 298
86Midazolam1件: Midazolam3件: D00550 ,
D00696 ,
D05028 		16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298
87MONITOR1件: Methamidophos---20件: 2, 11, 13, 19, 28, 46, 49, 58, 65, 70, 81, 85, 86, 98, 113, 118, 129, 298, 299, 300
88Morphine1件: Morphine3件: D00842 ,
D02271 ,
D08233 		1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬6件: 36, 46, 70, 85, 86, 298
89Morphine, buprenorphine, pethidine, tramaldol, metamizole and acetylsalicylacid (Analgesics)4件: Buprenorphine,
Meperidine,
Metamizole,
Morphine		8件: D00836 ,
D00842 ,
D01383 ,
D02271 ,
D07132 ,
D08188 ,
D08233 ,
D08343 		2件: OPRK1,
OPRM1 💬		3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 298
90MS1819----2件: 298, 299
91MS1819-SD1件: MS-1819---2件: 298, 299
92Multienzymes (lipase, protease etc.)----2件: 298, 299
93Namisol----2件: 13, 298
94Nexium (esomeprazole magnesium)2件: Esomeprazole,
Magnesium		4件: D01984 ,
D04056 ,
D07917 ,
D09339 		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 298
95NI-03----1件: 298
96Omeprazole1件: Omeprazole4件: D00455 ,
D01207 ,
D05259 ,
D05261 		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬16件: 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299
97Other: Carbon monoxide-bubbled mediums2件: Activated charcoal,
Carbon monoxide		1件: D09706 --1件: 298
98Other: EUS procedure----1件: 298
99Other: Laboratory Biomarker Analysis----21件: 11, 13, 14, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331
100Other: Low-intensity exercise therapy----1件: 298
101Other: No enzyme therapy----1件: 298
102Other: Nutrition counseling----1件: 298
103Other: Quality-of-Life Assessment----9件: 34, 36, 51, 62, 65, 96, 283, 286, 298
104Other: Questionnaire Administration----4件: 16, 34, 51, 298
105Oxycodone1件: Oxycodone3件: D03783 ,
D05312 ,
D05462 		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬7件: 6, 13, 46, 70, 226, 231, 298
106Oxycodone Depot ”Sandoz”, depot tablets1件: Oxycodone3件: D03783 ,
D05312 ,
D05462 		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 298
107OXYCODONE HYDROCHLORIDE1件: Oxycodone3件: D03783 ,
D05312 ,
D05462 		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬4件: 6, 70, 226, 298
108Oxycodonhydrochlorid ”Lannacher”, depot tablets----1件: 298
109Oxynorm----1件: 298
110Pancreatic enzyme(Pancreatin Enteric-coated Capsules or Oryz-Aspergillus Enzyme and Pancreatin Table), antidiabetic medicine(Acarbose Tablets, Glucophage, Glimepirde Tablets)2件: Acarbose,
Pancrelipase		2件: D00216 ,
D05349 		5件: AMY2A,
AMY2B,
GAA,
GANC,
MGAM 💬		7件: Carbohydrate digestion and absorption, Galactose metabolism, Lysosome, Metabolic pathways, Pancreatic secretion, Salivary secretion, Starch and sucrose metabolism 💬1件: 298
111Pancreatic enzymes----1件: 298
112Pancreatin1件: Pancrelipase1件: D05349 --2件: 298, 299
113Pancrelipase1件: Pancrelipase1件: D05349 --2件: 298, 299
114Pancrelipase Delayed Release Capsule1件: Pancrelipase1件: D05349 --2件: 298, 299
115Pancrelipase/Pancreas Powder1件: Pancrelipase1件: D05349 --2件: 298, 299
116Panzytrat----1件: 298
117Panzytrat 25.000----1件: 298
118Panzytrat 25.000 FIP-E units of Lipase----1件: 298
119Pentoxifylline1件: Pentoxifylline1件: D00501 --10件: 26, 56, 84, 93, 96, 113, 220, 222, 296, 298
120Perflubutane1件: Perflubutane1件: D05440 --2件: 298, 300
121Pethidine1件: Meperidine2件: D01383 ,
D08343 		1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 298
122PFD----3件: 51, 117, 298
123Pioglitazone1件: Pioglitazone2件: D00945 ,
D08378 		1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299
124PL 00512/0150----1件: 298
125Pregabalin1件: Pregabalin1件: D02716 4件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4 💬		7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬5件: 13, 36, 46, 70, 298
126Prolastin----3件: 231, 298, 299
127Prolastin-C1件: Alpha-1-proteinase inhibitor---2件: 231, 298
128Proton pump inhibitor (PPI)----1件: 298
129Radiation: UV-filtered light.----1件: 298
130Radiation: UVB----1件: 298
131Recombinant microbial lipase----1件: 298
132Recombinant Microbial Lipase SLV339----1件: 298
133REGN475/SAR164877----1件: 298
134Reparixin1件: Reparixin1件: D08984 2件: CXCR1,
CXCR2 💬		7件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, Human cytomegalovirus infection, Phospholipase D signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬2件: 298, 299
135RG1068 (Synthetic Human Secretin)1件: Secretin human---1件: 298
136RVG 13760----1件: 298
137S-Ketamin----1件: 298
138SA----5件: 6, 30, 60, 118, 298
139SA-001----1件: 298
140Secretin1件: Secretin human---1件: 298
141Selenium1件: Selenium---4件: 13, 96, 278, 298
142Simvastatin1件: Simvastatin1件: D00434 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬21件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310
143SLV339----1件: 298
144Somatuline----2件: 67, 298
145Somatuline Autogel 90 mg1件: Lanreotide---1件: 298
146Soy bread----1件: 298
147Synthetic human secretin1件: Secretin human---1件: 298
148Tanezumab1件: Tanezumab1件: D09387 1件: NGF 💬9件: Apoptosis, Calcium signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬2件: 226, 298
149Tetrahydro-6,6,9-tri methyl-3-penthyl-6 H-dibenzo[ b,d ]pyran-1-ol----1件: 298
150Tetrahydrocannabinol1件: Dronabinol1件: D00306 2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬4件: 8, 13, 36, 298
151Thalidomide1件: Thalidomide1件: D00754 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬20件: 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331
152Time interval between ESWL and ERCP is 12-36h----1件: 298
153Time interval between ESWL and ERCP is 12h----1件: 298
154Time interval between ESWL and ERCP is greater than 36h----1件: 298
155Tocopherol1件: Tocopherol1件: D02332 --5件: 13, 49, 206, 257, 298
156Triamcinolone1件: Triamcinolone5件: D00385 ,
D00983 ,
D00984 ,
D00985 ,
D06216 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬10件: 35, 46, 56, 70, 90, 96, 107, 162, 226, 298
157Tyr----2件: 75, 298
158VIOKASE 16----1件: 298
159Viokase 16 (pancrelipase) + Nexium2件: Esomeprazole,
Pancrelipase		5件: D01984 ,
D04056 ,
D05349 ,
D07917 ,
D09339 		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 298
160Viokase® 16----1件: 298
161Vitamin D1件: Vitamin D---24件: 3, 13, 15, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 98, 179, 222, 228, 235, 256, 274, 298, 299
162Vitamin D 100ug1件: Vitamin D---1件: 298
163Vitamin D 10ug1件: Vitamin D---1件: 298
164Yarrowia lipolytica lipase----1件: 298
165Zenpep----2件: 298, 299
166ZENTASE----1件: 298